Heritage Cannabis Holdings (CANN.C) announced the execution of a binding letter of intent with pharmaceutical film developer, IntelGenx (IGX.V), to supply CBD filmstrips for the Canadian and Australian markets, according to a press release.

IntelGenx’s duties will include manufacturing filmstrips with 10 mg of CBD using its VersaFilm technology for distribution and sale in Canada and Australia, according to the LOI. IntelGenz will receive a manufacturing margin and a double-digit royalty on the gross margin based on product sales.

“We value this partnership with IntelGenx given their leadership in developing high quality pharmaceutical products with their proprietary filmstrip platforms. This supply deal is a first step in building a long-term relationship to develop high quality, data driven and well-tested products for the Canadian and international medical cannabis and hemp markets, including Australia and the United States,” said Clint Sharples, CEO of Heritage.

Heritage will supply the CBD material and IntelGenx will manufacture and supply filmstrips in Canada and Australia on both a non and semi-exclusive basis. The LOI also includes provisions for future co-development and CBD and THC filmstrips using resources from both companies.

“This LOI further supports the potential of our VersaFilm® technology to provide medical cannabis consumers with an alternative, more discreet and convenient administration method, with the possibility of a superior therapeutic profile,” said Dr. Horst G. Zerbe, CEO of IntelGenx.

The filmstrips will be produced at IntelGenx facility under Canadian GPP conditions and registered with Health Canada as a cannabis product under the Cannabis Act, and with the Australian Department of Health’s Therapeutic Goods Administration as a medicinal cannabis product under the Narcotic Drugs Act.

—Joseph Morton

Written By:

Joseph Morton

Joseph is a Vancouver-based author and journalist with both a communications degree and journalism diploma (and a few novels) under his belt. His joie de vivre is to spin difficult technical topics into more human-centric narratives. Buy him a coffee and he'll talk your ear off for hours about privacy issues, blockchain, cryptocurrency and martial arts. Don't talk to him if you're either a tomato, a bully, or if you're not a fan of either 1984 or Tender is the Night. No. You can still talk to him. Just be prepared to be told why you're wrong.

More By This Author
Australian cannabis markets
Australian Department of Health's Therapeutic Goods Administration
Canadian cannabis markets
Cannabis Act
cannabis delivery systems
Health Canada
Heritage Cannabis
Heritage Cannabis Holdings
Narcotic Drugs Act
0 0 votes
Article Rating
Notify of
Inline Feedbacks
View all comments
Would love your thoughts, please comment.x